2O3F - Header Asymmetric Unit

HEADER TRANSCRIPTION 01-DEC-06 2O3F

TITLE STRUCTURAL GENOMICS, THE CRYSTAL STRUCTURE OF THE N- TITLE 2 TERMINAL DOMAIN OF THE PUTATIVE TRANSCRIPTIONAL REGULATOR TITLE 3 YBBH FROM BACILLUS SUBTILIS SUBSP. SUBTILIS STR. 168.

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE HTH-TYPE TRANSCRIPTIONAL REGULATOR YBBH; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 1-108; COMPND 5 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 STRAIN: 168; SOURCE 5 VARIANT: BACILLUS SUBTILIS SUBSP. SUBTILIS; SOURCE 6 GENE: YBBH; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PMCSG19

KEYWDS APC85504, PUTATIVE TRANSCRIPTIONAL REGULATOR YBBH, BACILLUS KEYWDS 2 SUBTILIS SUBSP. SUBTILIS STR. 168, STRUCTURAL GENOMICS, PSI- KEYWDS 3 2, PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR KEYWDS 4 STRUCTURAL GENOMICS, MCSG

EXPDTA X-RAY DIFFRACTION

AUTHOR K.TAN,L.BIGELOW,J.ABDULLAH,A.JOACHIMIAK,MIDWEST CENTER FOR AUTHOR 2 STRUCTURAL GENOMICS (MCSG)

REVDAT 2 24-FEB-09 2O3F 1 VERSN REVDAT 1 02-JAN-07 2O3F 0

JRNL AUTH K.TAN,L.BIGELOW,J.ABDULLAH,A.JOACHIMIAK JRNL TITL THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF JRNL TITL 2 THE PUTATIVE TRANSCRIPTIONAL REGULATOR YBBH FROM JRNL TITL 3 BACILLUS SUBTILIS SUBSP. SUBTILIS STR. 168. JRNL REF TO BE PUBLISHED JRNL REFN

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 26813 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1400 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1604 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1924 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.111 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.109 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.079 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.481 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.960 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2017 ; 0.018 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2732 ; 1.725 ; 2.068 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 257 ; 5.202 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 69 ;19.794 ;23.913 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 312 ;15.373 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.373 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 302 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1448 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1036 ; 0.212 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1361 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 132 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 77 ; 0.223 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.135 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1280 ; 1.309 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1996 ; 2.145 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 788 ; 2.796 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 730 ; 4.450 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS

REMARK 4 REMARK 4 2O3F COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-06. REMARK 100 THE RCSB ID CODE IS RCSB040637.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97904 REMARK 200 MONOCHROMATOR : SI 111 CRYSTAL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-3 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28223 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 25.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 40.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.47800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.420 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM ACETATE, 2M AMMONIUM REMARK 280 SULFATE, PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 3 CHAIN(S). AUTHORS STATE THAT THE REMARK 300 BIOLOGICAL UNIT OF THIS PROTEIN IS UNKNOWN.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 TYR A 84 REMARK 465 ARG A 85 REMARK 465 ASP A 86 REMARK 465 ILE A 87 REMARK 465 VAL A 88 REMARK 465 PRO A 89 REMARK 465 HIS A 90 REMARK 465 GLU A 91 REMARK 465 PRO A 92 REMARK 465 LEU A 93 REMARK 465 PRO A 94 REMARK 465 SER A 95 REMARK 465 ILE A 96 REMARK 465 SER A 97 REMARK 465 GLU A 98 REMARK 465 LYS A 99 REMARK 465 THR A 100 REMARK 465 ALA A 101 REMARK 465 GLY A 102 REMARK 465 ASN A 103 REMARK 465 ALA A 104 REMARK 465 ILE A 105 REMARK 465 GLN A 106 REMARK 465 ALA A 107 REMARK 465 ILE A 108 REMARK 465 SER B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 465 MSE B 1 REMARK 465 TYR B 84 REMARK 465 ARG B 85 REMARK 465 ASP B 86 REMARK 465 ILE B 87 REMARK 465 VAL B 88 REMARK 465 PRO B 89 REMARK 465 HIS B 90 REMARK 465 GLU B 91 REMARK 465 PRO B 92 REMARK 465 LEU B 93 REMARK 465 PRO B 94 REMARK 465 SER B 95 REMARK 465 ILE B 96 REMARK 465 SER B 97 REMARK 465 GLU B 98 REMARK 465 LYS B 99 REMARK 465 THR B 100 REMARK 465 ALA B 101 REMARK 465 GLY B 102 REMARK 465 ASN B 103 REMARK 465 ALA B 104 REMARK 465 ILE B 105 REMARK 465 GLN B 106 REMARK 465 ALA B 107 REMARK 465 ILE B 108 REMARK 465 SER C -2 REMARK 465 ASN C -1 REMARK 465 ALA C 0 REMARK 465 TYR C 84 REMARK 465 ARG C 85 REMARK 465 ASP C 86 REMARK 465 ILE C 87 REMARK 465 VAL C 88 REMARK 465 PRO C 89 REMARK 465 HIS C 90 REMARK 465 GLU C 91 REMARK 465 PRO C 92 REMARK 465 LEU C 93 REMARK 465 PRO C 94 REMARK 465 SER C 95 REMARK 465 ILE C 96 REMARK 465 SER C 97 REMARK 465 GLU C 98 REMARK 465 LYS C 99 REMARK 465 THR C 100 REMARK 465 ALA C 101 REMARK 465 GLY C 102 REMARK 465 ASN C 103 REMARK 465 ALA C 104 REMARK 465 ILE C 105 REMARK 465 GLN C 106 REMARK 465 ALA C 107 REMARK 465 ILE C 108

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 48 -156.37 -132.76 REMARK 500 SER B 48 -155.15 -134.86 REMARK 500 SER C 48 -153.49 -127.39 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 201 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 202 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 203 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 204 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 205 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 206 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 207 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 208 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 209 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 210 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 211 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 212 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 213 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 214 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 215

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: APC85504 RELATED DB: TARGETDB

DBREF 2O3F A 1 108 UNP Q45581 YBBH_BACSU 1 108 DBREF 2O3F B 1 108 UNP Q45581 YBBH_BACSU 1 108 DBREF 2O3F C 1 108 UNP Q45581 YBBH_BACSU 1 108

SEQADV 2O3F SER A -2 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ASN A -1 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ALA A 0 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F MSE A 1 UNP Q45581 MET 1 MODIFIED RESIDUE SEQADV 2O3F MSE A 12 UNP Q45581 MET 12 MODIFIED RESIDUE SEQADV 2O3F MLY A 13 UNP Q45581 LYS 13 MODIFIED RESIDUE SEQADV 2O3F MLY A 15 UNP Q45581 LYS 15 MODIFIED RESIDUE SEQADV 2O3F MLY A 33 UNP Q45581 LYS 33 MODIFIED RESIDUE SEQADV 2O3F MLY A 58 UNP Q45581 LYS 58 MODIFIED RESIDUE SEQADV 2O3F MLY A 69 UNP Q45581 LYS 69 MODIFIED RESIDUE SEQADV 2O3F MSE A 70 UNP Q45581 MET 70 MODIFIED RESIDUE SEQADV 2O3F SER B -2 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ASN B -1 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ALA B 0 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F MSE B 1 UNP Q45581 MET 1 MODIFIED RESIDUE SEQADV 2O3F MSE B 12 UNP Q45581 MET 12 MODIFIED RESIDUE SEQADV 2O3F MLY B 13 UNP Q45581 LYS 13 MODIFIED RESIDUE SEQADV 2O3F MLY B 15 UNP Q45581 LYS 15 MODIFIED RESIDUE SEQADV 2O3F MLY B 33 UNP Q45581 LYS 33 MODIFIED RESIDUE SEQADV 2O3F MLY B 58 UNP Q45581 LYS 58 MODIFIED RESIDUE SEQADV 2O3F MLY B 69 UNP Q45581 LYS 69 MODIFIED RESIDUE SEQADV 2O3F MSE B 70 UNP Q45581 MET 70 MODIFIED RESIDUE SEQADV 2O3F SER C -2 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ASN C -1 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F ALA C 0 UNP Q45581 CLONING ARTIFACT SEQADV 2O3F MSE C 1 UNP Q45581 MET 1 MODIFIED RESIDUE SEQADV 2O3F MSE C 12 UNP Q45581 MET 12 MODIFIED RESIDUE SEQADV 2O3F MLY C 13 UNP Q45581 LYS 13 MODIFIED RESIDUE SEQADV 2O3F MLY C 15 UNP Q45581 LYS 15 MODIFIED RESIDUE SEQADV 2O3F MLY C 33 UNP Q45581 LYS 33 MODIFIED RESIDUE SEQADV 2O3F MLY C 58 UNP Q45581 LYS 58 MODIFIED RESIDUE SEQADV 2O3F MLY C 69 UNP Q45581 LYS 69 MODIFIED RESIDUE SEQADV 2O3F MSE C 70 UNP Q45581 MET 70 MODIFIED RESIDUE

SEQRES 1 A 111 SER ASN ALA MSE ALA THR GLY GLY LEU ALA ILE ILE GLN SEQRES 2 A 111 SER MSE MLY HIS MLY LEU PRO PRO SER GLU ARG LYS LEU SEQRES 3 A 111 ALA ASP TYR ILE LEU ALA HIS PRO HIS MLY ALA ILE GLU SEQRES 4 A 111 SER THR VAL ASN GLU ILE SER ALA LEU ALA ASN SER SER SEQRES 5 A 111 ASP ALA ALA VAL ILE ARG LEU CYS MLY SER LEU GLY LEU SEQRES 6 A 111 LYS GLY PHE GLN ASP LEU MLY MSE ARG VAL ALA GLY ASP SEQRES 7 A 111 LEU ALA LYS PRO THR PHE GLN GLY TYR ARG ASP ILE VAL SEQRES 8 A 111 PRO HIS GLU PRO LEU PRO SER ILE SER GLU LYS THR ALA SEQRES 9 A 111 GLY ASN ALA ILE GLN ALA ILE SEQRES 1 B 111 SER ASN ALA MSE ALA THR GLY GLY LEU ALA ILE ILE GLN SEQRES 2 B 111 SER MSE MLY HIS MLY LEU PRO PRO SER GLU ARG LYS LEU SEQRES 3 B 111 ALA ASP TYR ILE LEU ALA HIS PRO HIS MLY ALA ILE GLU SEQRES 4 B 111 SER THR VAL ASN GLU ILE SER ALA LEU ALA ASN SER SER SEQRES 5 B 111 ASP ALA ALA VAL ILE ARG LEU CYS MLY SER LEU GLY LEU SEQRES 6 B 111 LYS GLY PHE GLN ASP LEU MLY MSE ARG VAL ALA GLY ASP SEQRES 7 B 111 LEU ALA LYS PRO THR PHE GLN GLY TYR ARG ASP ILE VAL SEQRES 8 B 111 PRO HIS GLU PRO LEU PRO SER ILE SER GLU LYS THR ALA SEQRES 9 B 111 GLY ASN ALA ILE GLN ALA ILE SEQRES 1 C 111 SER ASN ALA MSE ALA THR GLY GLY LEU ALA ILE ILE GLN SEQRES 2 C 111 SER MSE MLY HIS MLY LEU PRO PRO SER GLU ARG LYS LEU SEQRES 3 C 111 ALA ASP TYR ILE LEU ALA HIS PRO HIS MLY ALA ILE GLU SEQRES 4 C 111 SER THR VAL ASN GLU ILE SER ALA LEU ALA ASN SER SER SEQRES 5 C 111 ASP ALA ALA VAL ILE ARG LEU CYS MLY SER LEU GLY LEU SEQRES 6 C 111 LYS GLY PHE GLN ASP LEU MLY MSE ARG VAL ALA GLY ASP SEQRES 7 C 111 LEU ALA LYS PRO THR PHE GLN GLY TYR ARG ASP ILE VAL SEQRES 8 C 111 PRO HIS GLU PRO LEU PRO SER ILE SER GLU LYS THR ALA SEQRES 9 C 111 GLY ASN ALA ILE GLN ALA ILE

MODRES 2O3F MSE A 1 MET SELENOMETHIONINE MODRES 2O3F MSE A 12 MET SELENOMETHIONINE MODRES 2O3F MLY A 13 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY A 15 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY A 33 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY A 58 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY A 69 LYS N-DIMETHYL-LYSINE MODRES 2O3F MSE A 70 MET SELENOMETHIONINE MODRES 2O3F MSE B 12 MET SELENOMETHIONINE MODRES 2O3F MLY B 13 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY B 15 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY B 33 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY B 58 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY B 69 LYS N-DIMETHYL-LYSINE MODRES 2O3F MSE B 70 MET SELENOMETHIONINE MODRES 2O3F MSE C 1 MET SELENOMETHIONINE MODRES 2O3F MSE C 12 MET SELENOMETHIONINE MODRES 2O3F MLY C 13 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY C 15 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY C 33 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY C 58 LYS N-DIMETHYL-LYSINE MODRES 2O3F MLY C 69 LYS N-DIMETHYL-LYSINE MODRES 2O3F MSE C 70 MET SELENOMETHIONINE

HET MSE A 1 8 HET MSE A 12 8 HET MLY A 13 11 HET MLY A 15 11 HET MLY A 33 11 HET MLY A 58 11 HET MLY A 69 11 HET MSE A 70 8 HET MSE B 12 8 HET MLY B 13 11 HET MLY B 15 11 HET MLY B 33 11 HET MLY B 58 11 HET MLY B 69 11 HET MSE B 70 8 HET MSE C 1 8 HET MSE C 12 8 HET MLY C 13 11 HET MLY C 15 11 HET MLY C 33 11 HET MLY C 58 11 HET MLY C 69 11 HET MSE C 70 8 HET SO4 C 201 5 HET SO4 B 202 5 HET SO4 A 203 5 HET SO4 B 204 5 HET SO4 C 205 5 HET SO4 A 206 5 HET SO4 B 207 5 HET SO4 C 208 5 HET SO4 A 209 5 HET SO4 A 210 5 HET SO4 B 211 5 HET SO4 C 212 5 HET SO4 C 213 5 HET SO4 A 214 5 HET SO4 B 215 5

HETNAM MSE SELENOMETHIONINE HETNAM MLY N-DIMETHYL-LYSINE HETNAM SO4 SULFATE ION

FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 1 MLY 15(C8 H18 N2 O2) FORMUL 4 SO4 15(O4 S 2-) FORMUL 19 HOH *137(H2 O)

HELIX 1 1 GLY A 4 MLY A 13 1 10 HELIX 2 2 HIS A 14 LEU A 16 5 3 HELIX 3 3 PRO A 17 HIS A 30 1 14 HELIX 4 4 HIS A 30 GLU A 36 1 7 HELIX 5 5 THR A 38 ALA A 46 1 9 HELIX 6 6 SER A 49 LEU A 60 1 12 HELIX 7 7 GLY A 64 LYS A 78 1 15 HELIX 8 8 PRO A 79 GLN A 82 5 4 HELIX 9 9 GLY B 4 MLY B 13 1 10 HELIX 10 10 PRO B 17 HIS B 30 1 14 HELIX 11 11 HIS B 30 ILE B 35 1 6 HELIX 12 12 THR B 38 ALA B 46 1 9 HELIX 13 13 SER B 49 LEU B 60 1 12 HELIX 14 14 GLY B 64 LYS B 78 1 15 HELIX 15 15 PRO B 79 GLN B 82 5 4 HELIX 16 16 GLY C 4 MLY C 13 1 10 HELIX 17 17 HIS C 14 LEU C 16 5 3 HELIX 18 18 PRO C 17 HIS C 30 1 14 HELIX 19 19 HIS C 30 ILE C 35 1 6 HELIX 20 20 THR C 38 ASN C 47 1 10 HELIX 21 21 SER C 49 LEU C 60 1 12 HELIX 22 22 GLY C 64 LYS C 78 1 15 HELIX 23 23 PRO C 79 GLN C 82 5 4

LINK C MSE A 1 N ALA A 2 1555 1555 1.33 LINK C SER A 11 N MSE A 12 1555 1555 1.32 LINK C MSE A 12 N MLY A 13 1555 1555 1.33 LINK C MLY A 13 N HIS A 14 1555 1555 1.34 LINK C HIS A 14 N MLY A 15 1555 1555 1.33 LINK C MLY A 15 N LEU A 16 1555 1555 1.33 LINK C HIS A 32 N MLY A 33 1555 1555 1.34 LINK C MLY A 33 N ALA A 34 1555 1555 1.32 LINK C CYS A 57 N MLY A 58 1555 1555 1.33 LINK C MLY A 58 N SER A 59 1555 1555 1.34 LINK C LEU A 68 N MLY A 69 1555 1555 1.33 LINK C MLY A 69 N MSE A 70 1555 1555 1.35 LINK C MSE A 70 N ARG A 71 1555 1555 1.35 LINK C SER B 11 N MSE B 12 1555 1555 1.32 LINK C MSE B 12 N MLY B 13 1555 1555 1.34 LINK C MLY B 13 N HIS B 14 1555 1555 1.34 LINK C HIS B 14 N MLY B 15 1555 1555 1.34 LINK C MLY B 15 N LEU B 16 1555 1555 1.33 LINK C HIS B 32 N MLY B 33 1555 1555 1.34 LINK C MLY B 33 N ALA B 34 1555 1555 1.33 LINK C CYS B 57 N MLY B 58 1555 1555 1.32 LINK C MLY B 58 N SER B 59 1555 1555 1.34 LINK C LEU B 68 N MLY B 69 1555 1555 1.33 LINK C MLY B 69 N MSE B 70 1555 1555 1.35 LINK C MSE B 70 N ARG B 71 1555 1555 1.34 LINK C MSE C 1 N ALA C 2 1555 1555 1.34 LINK C SER C 11 N MSE C 12 1555 1555 1.33 LINK C MSE C 12 N MLY C 13 1555 1555 1.34 LINK C MLY C 13 N HIS C 14 1555 1555 1.34 LINK C HIS C 14 N MLY C 15 1555 1555 1.33 LINK C MLY C 15 N LEU C 16 1555 1555 1.33 LINK C HIS C 32 N MLY C 33 1555 1555 1.33 LINK C MLY C 33 N ALA C 34 1555 1555 1.32 LINK C CYS C 57 N MLY C 58 1555 1555 1.33 LINK C MLY C 58 N SER C 59 1555 1555 1.34 LINK C LEU C 68 N MLY C 69 1555 1555 1.33 LINK C MLY C 69 N MSE C 70 1555 1555 1.35 LINK C MSE C 70 N ARG C 71 1555 1555 1.34

CISPEP 1 GLN C 82 GLY C 83 0 4.23

SITE 1 AC1 5 ALA C 29 HIS C 30 PRO C 31 HIS C 32 SITE 2 AC1 5 MLY C 33 SITE 1 AC2 7 HIS B 30 PRO B 31 HIS B 32 MLY B 33 SITE 2 AC2 7 HOH B 228 HOH B 247 MLY C 15 SITE 1 AC3 6 ALA A 29 HIS A 30 PRO A 31 HIS A 32 SITE 2 AC3 6 MLY A 33 MLY B 15 SITE 1 AC4 4 SER B 49 ARG B 55 HOH B 244 HOH B 249 SITE 1 AC5 7 SER C 49 ALA C 51 ALA C 52 ARG C 55 SITE 2 AC5 7 SO4 C 212 HOH C 244 HOH C 256 SITE 1 AC6 5 SER A 49 ALA A 51 ALA A 52 ARG A 55 SITE 2 AC6 5 HOH A 256 SITE 1 AC7 3 GLN B 10 MLY B 13 HIS B 14 SITE 1 AC8 3 GLN C 10 MLY C 13 HIS C 14 SITE 1 AC9 3 GLN A 10 MLY A 13 HIS A 14 SITE 1 BC1 5 PRO A 17 PRO A 18 SER A 19 GLU A 20 SITE 2 BC1 5 ARG A 55 SITE 1 BC2 5 PRO B 17 PRO B 18 SER B 19 GLU B 20 SITE 2 BC2 5 ARG B 55 SITE 1 BC3 6 PRO C 17 PRO C 18 SER C 19 GLU C 20 SITE 2 BC3 6 ARG C 55 SO4 C 205 SITE 1 BC4 6 ILE C 54 GLY C 64 PHE C 65 GLN C 66 SITE 2 BC4 6 HOH C 225 HOH C 240 SITE 1 BC5 5 GLY A 64 PHE A 65 GLN A 66 HOH A 220 SITE 2 BC5 5 HOH A 221 SITE 1 BC6 5 GLY B 64 PHE B 65 GLN B 66 HOH B 238 SITE 2 BC6 5 HOH B 250

CRYST1 58.898 48.060 58.854 90.00 119.92 90.00 P 1 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.016979 0.000000 0.009771 0.00000

SCALE2 0.000000 0.020807 0.000000 0.00000

SCALE3 0.000000 0.000000 0.019604 0.00000